LIVE QUOTE
Universal Health Services, Inc. UHS
Healthcare · Medical - Care Facilities · NYSE
$182.10
Market Cap$10.0B
P/E Ratio12.0
Dividend Yield0.40%
Beta1.26
Employees78,400

Investment Thesis

Universal Health Services, Inc. (UHS) is a BUY at current prices, primarily due to its strong positioning in the behavioral health segment and the robust demand for health services. The market appears to be undervaluing UHS's potential for growth, especially as healthcare continues to shift toward integrated and accessible models. With the increasing prevalence of mental health issues and the company’s strategic focus on expanding its behavioral health facilities, UHS is well-positioned for sustained revenue growth.

Competitive Moat

characterized by scale economies and regulatory advantages. The company’s extensive network of 363 inpatient facilities provides a strong barrier to entry for new competitors, while its established relationships with insurers and regulatory bodies reinforce its market position. The durability of this advantage is likely to persist over the next 5-10 years, especially as demand for behavioral health services surges. However, top threats include emerging telehealth competitors and potential regulatory changes that could impact reimbursement rates.

Growth Engine

Future revenue growth for UHS is expected to stem largely from the expansion of its behavioral health services, which represent a rapidly growing segment within the healthcare industry. The total addressable market (TAM) for mental health services is projected to expand significantly, with increasing recognition of mental health issues driving demand. UHS is actively pursuing organic growth through new facility openings and enhancements to existing services, while also considering strategic acquisitions to bolster its market share. The company is currently gaining market share in the behavioral health sector, which positions it favorably against its competitors.

This analysis is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Morningstar Investor
Analyst ratings, fair value, moat
Research UHS
Robinhood
$0 commission trades
Trade UHS
Webull
Extended-hours, options, charts
Trade UHS
TradingView
Advanced charts & screeners
Chart UHS
We may earn a commission if you open an account through our links, at no extra cost to you.
Loading chart...

Frequently Asked Questions

As of 2026-04-09, UHS is trading at $182.1, but it has a P/E ratio that is not applicable (N/A), which makes it difficult to assess its valuation relative to other stocks in the healthcare sector. Additionally, without a specified market cap, potential investors may want to consider other valuation metrics and market conditions before making a decision.
UHS does not currently pay a dividend, as indicated by the absence of a dividend yield in the provided data.
UHS operates in the healthcare sector, specifically within the medical - care facilities industry, providing a range of inpatient and outpatient services.
The market cap of UHS is not provided in the data, making it difficult to classify the company in terms of size. Generally, companies are categorized as mega-cap, large-cap, mid-cap, small-cap, or micro-cap based on their market capitalization.
UHS faces competition from other healthcare providers such as HCA Healthcare, Inc. and Tenet Healthcare Corporation, both of which operate in the same medical care facilities industry.
FAQ generated 2026-04-09

Related Reading

Related Stocks

← View in Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Past performance is not indicative of future results. All investments carry risk, including the possible loss of principal. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms